EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57

Abstract

CURRENT PRACTICE OF INTRAVENOUS TO ORAL CONVERSION OF ANTIBIOTICS AT A TERTIARY CARE HOSPITAL: A PROSPECTIVE STUDY

Dr. Sneha Sebastian*, Dr. Priya Saji Koliyakodu, Dr. Sherine Justin, Gayatri P. Sapkale, Dr. Vishnu V. K.

ABSTRACT

Introduction: The patients admitted in general ward of a hospital with severe infections who adequately absorb oral medication and initially require IV therapy can be safely switched to oral therapy within 2-3 days. There are number of advantages like fewer complications and decreased length of hospital stay (LOHS). Aim: To evaluate the practice of switching from IV to oral antibiotics, identification of IV complications in non-converted patients, case related barriers to an early switch and thereby influence in LOHS. Materials and Methods: A prospective observational study was conducted over a period of 3 months from March-May 2019. NUH guidelines were used to evaluate the early switch based on clinical stability. Clinical based end points such as complications, barriers for conversion, duration of antibiotics and LOHS were assessed. Results: The study reveals that among antibiotic courses, 51% and 49% were converted and non-converted respectively. Sequential conversion therapy was more commonly used than switch and step-down therapy. IV complications (49%) were identified in non-converted patients, pain (57.1%) followed by phlebitis (36.7%) and extravasation (6.12%). By means of case-specific interviews, barriers (49%) were identified for conversions. The most frequently mentioned barriers were “supervisor’s opinion” in 9 (18.3%) cases followed by different patient factors. Duration of IV therapy and LOHS for patient population had significantly (p<0.05) decreased following IV to PO conversions compared to non-conversion therapy. Conclusion: Switching of antibiotics based on predefined criteria for clinical stability lead to decreased rate of complication from IV lines and thereby decreased LOHS.

Keywords: IV to PO conversions, switch therapy, sequential therapy, step-down therapy.


[Full Text Article]

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 January 2022 Issue has been Published, Kindly check it on https://www.ejpmr.com/issue

  • EJPMR: JANUARY ISSUE PUBLISHED

    JANUARY Issue has been successfully launched on 1 January 2022.

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing Scholar Article Journal Index (SAJI) International Scientific Indexing ( ISI )